T1D-Plus study with Dexcom
Description
T1D-Plus trial is a randomised, adaptive, open label, parallel group, multi-centre Platform trial in adults with newly diagnosed type 1 diabetes). The T1D Plus trial, funded by JDRF, sponsored by CU, started on 30th September 2022, led by Colin Dayan. Since that time, additional arms of the trial have been funded by separate grants from the Helmsley Charitable Trust and JDRF Australia. Funding was agreed in Dec 2023.
An endpoint in the trial is the recording of glucose levels by a continuous glucose monitoring device. These devices are marketed by different companies with different specifications.
The rest of this notice
The tender documents, the buyer's named contact, the award history and our AI analysis for this notice are part of Pro. Start a free trial to open the full record.
- Download the tender documents
- Contact the buyer directly
- See who won, and for how much
- Read the AI analysis of scope and risk
- Get alerts for tenders like this one
14 days free. No card required.
Guides for bidders
New to public sector tendering? These short guides explain how the process works.